Work

Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease

Year: 2019

Type: article

Source: Parkinsonism & Related Disorders

DOI: 10.1016/j.parkreldis.2019.04.006

Authors: Gwenn S. Smith, Kelly A. Mills, Greg M. Pontone, W. Stanley Anderson, Kate M. Perepezko, James Brasic, Yun Zhou, Jason Brandt, Christopher R. Butson, Daniel P. Holt, William B. Mathews, Robert F. Dannals, Dean F. Wong, Zoltan Mari

Institutions: Johns Hopkins University, Johns Hopkins Medicine, University of Utah, Cleveland Clinic, Lou Ruvo Brain Institute

Language: English

Topic: Neurological disorders and treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute on Aging, National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences

Awards: Institute for Clinical and Translational Research, Institute for Clinical and Translational Research, Anxiety in Parkinson's: Use of quantitative methods to guide rational treatment, Molecular Imaging of the Nicotinic Cholinergic Receptor in Parkinson's disease (PD): Implication of for understanding the neurobiology of cognitive impairment

OpenAlex ID: W2937204925

FWCI: 2.537

Cites: 37

Cited by: 24

Related to: 10